Please assess the completion status of the following clinical trial:

Trial Title: Increasing Infant Preventive Health Service Delivery in an Inner City Population

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Any child born at Denver Health Medical Center between 2/1/04 and 1/31/05 who receives primary care at one of 3 community health centers.~Exclusion Criteria:~* No medical care in the Denver Health community health system after 42 days of age.~* Birthweight less than 1500 grams.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Historical Cohort (Type: NO_INTERVENTION): This study will first examine risk factors in a defined population of inner city children, using a historical cohort.
- Reminder Recall Outreach (Type: ACTIVE_COMPARATOR): To determine how well Reminder Recall Outreach will increase immunization rates and well child care delivery in those children most at risk for falling through the cracks. These studies will be conducted in the Denver Health community health network, the largest integrated community health care system in the United States.
- Case Management (Type: ACTIVE_COMPARATOR): To determine how well Case Management will increase immunization rates and well child care delivery in those children most at risk for falling through the cracks. These studies will be conducted in the Denver Health community health network, the largest integrated community health care system in the United States.
- Patient Navigation (Type: ACTIVE_COMPARATOR): To determine how well Patient Navigation will increase immunization rates and well child care delivery in those children most at risk for falling through the cracks. These studies will be conducted in the Denver Health community health network, the largest integrated community health care system in the United States.

Based on this trial design, predict the completion outcome and termination type (if applicable).